Key result
Wearables and smartphone apps show promise for early AF detection and improved adherence.
Why the study?
Traditional approaches to atrial fibrillation detection and management often lack accessibility, accuracy, and patient engagement despite advancements.
Mobile health technologies offer promising advancements in atrial fibrillation detection, patient adherence, and healthcare cost reduction, though challenges regarding device limitations, equity, and user anxiety remain.
May inform AF screening strategies; leaves open questions on equity, anxiety, and prospective outcome validation.
Atrial fibrillation (AF), a prevalent cardiac arrhythmia, poses significant risks for stroke and other severe complications. Traditional approaches frequently lack accessibility, accuracy, and patient engagement despite advancements in detection and management. The revolutionary effects of mobile health (mHealth) technologies on the treatment of AF are reviewed in this paper. These innovations, which make use of wearable technology, smartphone apps, and sophisticated algorithms, improve patient adherence, increase early detection, and lower healthcare costs. Better results are produced when real-time monitoring and patient-centered tools are incorporated into daily life because they empower people and allow for prompt interventions. However, issues like device restrictions, possible user anxiety, and fair access still exist. This study recognizes areas for additional research and development while highlighting the potential of mHealth to transform the management of AF.
No takes yet. Share an insight, caveat, or question.
Vyas et al. (2026) conducted a review in Atrial fibrillation. Mobile health (mHealth) technologies was evaluated. Mobile health technologies utilizing wearables and smartphone apps hold potential to improve early detection, patient adherence, and management in atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: